Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options?

Hepatocellular carcinoma (HCC) is the most frequently diagnosed primary tumor of the liver and is usually detected as advanced disease. It is an aggressive disease that often progresses rapidly when it fails to respond to treatment. As such, patients have limited opportunities to try different subse...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajappa, Senthil, Rau, Kun-Ming, Dattatreya, Palanki Satya, Ramaswamy, Anant, Fernandes, Philana, Pruthi, Aarohan, Cheng, Rebecca, Lukanowski, Mariusz, Huang, Yi-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258252/
https://www.ncbi.nlm.nih.gov/pubmed/35978665
http://dx.doi.org/10.4254/wjh.v14.i6.1074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258252/
https://www.ncbi.nlm.nih.gov/pubmed/35978665
http://dx.doi.org/10.4254/wjh.v14.i6.1074

Ejemplares similares